Elizabeth A. Mittendorf – Candidate for President Elect for ASCO

Elizabeth A. Mittendorf has been nominated as a Candidate for ASCO President-Elect.

The ASCO Nominating Committee has selected 13 distinguished members as candidates for leadership positions within the Society.

ASCO encourages all eligible members to vote for the new leaders of the Society.
Eligible members include those holding a Doctor of Medicine, Doctor of Osteopathy, Doctor of Philosophy, Doctor of Pharmacy, Doctor of Medical Science, Doctor of Nursing Science, Doctor of Nursing Practice, or an equivalent doctoral-level degree recognized by the Society and the Association, and who are in good standing as of October 14, 2024. Voting in the ASCO Election will earn eligible members a FASCO point.

The voting period ends on Tuesday, December 3, 2024, at 3:00 PM Eastern Standard Time. All ballots, whether submitted online or by paper, must be received by this deadline.

Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO, is the Director of the Breast Immuno-Oncology Program and Co-Director of the Breast Cancer Clinical Research Program at Dana-Farber Cancer Institute.

The Fellow of the American Society of Clinical Oncology (FASCO) distinction recognizes members for their volunteer engagement, and commitment to ASCO.

Elizabeth A. Mittendorf has built a career as a surgeon, researcher, and leader in the field of breast cancer and surgical oncology.

Her early career included serving as an Attending Surgeon at both the Malcolm Grow Medical Center at Andrews Air Force Base and Walter Reed Army Medical Center from 2001 to 2005, where she gained valuable experience in military medical settings.

Following this, she joined MD Anderson Cancer Center in Houston, Texas, where she worked as a Clinical Specialist and later as an Attending Surgeon in the Division of Surgery from 2005 to 2017.

During her time at MD Anderson, Dr.Mittendorf held several leadership roles, including Deputy Chair of the Department of Surgical Oncology’s Research Division from 2014 to 2017, and Director of Breast Surgical Oncology Research.

She was also appointed Co-Leader of the Breast Cancer Moon Shot initiative, a major focus at MD Anderson Cancer Center.

Her commitment to advancing cancer care continued as she became the Director of Research for Breast Surgical Oncology at Dana-Farber/Brigham and Women’s Cancer Center in Boston in 2018.

Dr. Mittendorf has also played an important role in numerous advisory and research committees at leading cancer institutions.

She has served on the External Advisory Boards for the NCI-designated Specialized Programs of Research Excellence (SPORE) in Breast Cancer at both Duke and Memorial Sloan Kettering Cancer Center, and she continues to be an active member of several other research initiatives.

She has chaired and contributed to committees for prominent organizations such as the American Society of Clinical Oncology (ASCO), where she has held multiple leadership roles, including Board Liaison for the Grants Selection Committee, and Board Liaison for the Quality Committee. She is also the Treasurer-Elect of ASCO, further demonstrating her leadership and dedication to improving cancer care globally.

Furthermore, she is involved in professional societies including the Society of Surgical Oncology (SSO), the American Association for Cancer Research (AACR), and the American College of Surgeons.

Education

Elizabeth A. Mittendorf’s began with a Bachelor of Mechanical Engineering in Biomedical Engineering from Duke University in 1992. She then earned her MD from Case Western Reserve University in 1996, before returning to academia for a PhD in Immunology at the University of Texas Graduate School of Biomedical Sciences in Houston, which she completed in 2012.

In 2021, she furthered her expertise in healthcare leadership by earning a Master of Healthcare Management from Harvard T.H. Chan School of Public Health.

Her postdoctoral training includes an internship and surgical residency at Case Western Reserve University, where she was appointed Chief Resident in 2001.

She then completed a fellowship in Surgical Oncology at MD Anderson Cancer Center, where she also served as Chief Administrative Fellow.

Awards and Honors

• ASCO Foundation Merit Award
• ASCO Breast Cancer Symposium Excellence in Clinical Research (2007)
• 9th Annual Lynn Sage Breast Cancer Symposium Fellow Travel Grant
• Lynn Sage Breast Cancer Symposium Excellence in Clinical Research (2008)
• Clinical Trainee of the Quarter, MD Anderson Cancer Center – Excellence in Patient Care (2008)
• Lotzova Memorial Research Prize, MD Anderson Cancer Center – Graduating Fellow in
• Recognition of Excellence in Research (2008)
• Advanced Care Practitioners Appreciation Award, MD Anderson Cancer Center – Graduating
• Fellow in Recognition of Excellence in Patient Care (2008)
• Charmingly Pink Breast Cancer Global Affair Award, Charmingly Pink Foundation
• Outstanding Research in Breast Cancer (2012)
• R. Lee Clark Fellow, MD Anderson Cancer Center – Excellence in Research (2014–2016)
• Faculty Scholar Award, MD Anderson Cancer Center – Excellence in Research (2016)
• Komen Scholar, Susan G. Komen – Leader in Breast Cancer Research and Advocacy (2017–2026)
• Pillars of Excellence Award, Mass General Brigham (BWH, DF/BWCC) – Awarded for Optimizing Collaboration (2020)

Interviews with Elizabeth A. Mittendorf

Elizabeth Mittendorf, MD, PhD, considers key takeaways from the Impassion-131 presented at ESMO 2020. – OBRoncology (October 2020)

Primary Analysis of AE37 Vaccine in Breast Cancer – Dr. Elizabeth Mittendorf ASCO 2014. – Oncology.TV (June 2014)

For more posts like this visit, oncodaily.com